Asia Pacific Intrathecal Pumps Market Size & Outlook
Asia Pacific intrathecal pumps market, 2017-2030 (US$M)
Related Markets
Asia Pacific intrathecal pumps market highlights
- The Asia Pacific intrathecal pumps market generated a revenue of USD 72.1 million in 2022.
- The market is expected to grow at a CAGR of 7% from 2023 to 2030.
- In terms of segment, morphine was the largest revenue generating type in 2022.
- Bupivacaine is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, India is expected to register the highest CAGR from 2023 to 2030.
Asia Pacific data book summary
| Market revenue in 2022 | USD 72.1 million |
| Market revenue in 2030 | USD 123.9 million |
| Growth rate | 7% (CAGR from 2022 to 2030) |
| Largest segment | Morphine |
| Fastest growing segment | Bupivacaine |
| Historical data covered | 2017 - 2021 |
| Base year for estimation | 2022 |
| Forecast period covered | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Baclofen, Bupivacaine, Clonidine, Morphine, Ziconotide, Other Type |
| Key market players worldwide | Medtronic PLC, Smiths Group PLC, Teleflex Inc, Johnson & Johnson, Medallion Therapeutics, Tricumed Medical Technology, Arrow International Inc, Flowonix |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 21.1% of the global intrathecal pumps market in 2022.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 123.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Intrathecal Pumps Market Scope
Intrathecal Pumps Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific intrathecal pumps market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to intrathecal pumps market will help companies and investors design strategic landscapes.
Morphine was the largest segment with a revenue share of 31.21% in 2022. Horizon Databook has segmented the Asia Pacific intrathecal pumps market based on baclofen, bupivacaine, clonidine, morphine, ziconotide, other type covering the revenue growth of each sub-segment from 2017 to 2030.
Large aging population in countries such as Japan, China, India, and Thailand is expected to drive the overall market. Moreover, growing prevalence of chronic diseases, such as neurological disorders, cancer, and pain associated with these diseases, is also expected to contribute to the market growth.
Since a large number of patients in the region seek chronic pain management therapies, various medical settings, mainly in countries like India and South Korea, offer these services. Moreover, favorable reimbursement policies in countries like South Korea for pain management using intrathecal drug delivery devices may also propel the market growth.
Reasons to subscribe to Asia Pacific intrathecal pumps market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific intrathecal pumps market databook
-
Our clientele includes a mix of intrathecal pumps market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific intrathecal pumps market, including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific intrathecal pumps market from 2017 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific intrathecal pumps market size, by country, 2017-2030 (US$M)
Asia Pacific Intrathecal Pumps Market Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
